Advertisement
News
Subscribe to MDT Magazine News

Federal Register: Informed Consent Elements

January 4, 2011 4:30 am | by U.S. Food & Drug Administration | Comments

The FDA is amending the current informed consent regulations to require that informed consent documents and processes for applicable drug (including biological products) and device clinical trials include a specific statement that clinical trial...

TOPICS:

Thornton returns to Ziopharm Oncology

January 4, 2011 3:45 am | by The Associated Press | Comments

Ziopharm Oncology Inc. said Tuesday that Mark O. Thornton has returned to the company to become executive vice president and chief development officer.Thornton will report to CEO and Chief Medical Officer Jonathan Lewis and will oversee the product development process. The executive is...

Marina Biotech, Inc. to Present at Biotech Showcase 2011

January 4, 2011 3:45 am | by The Associated Press | Comments

Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, announced today that it will present at Biotech Showcase 2011 on Tuesday, January 11, 2011, at 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time) at the Parc 55 Wyndham San Francisco Union...

Advertisement

Digirad Receives CE Mark for ergo(TM) Solid-State, General Imaging Nuclear Medicine Camera

January 4, 2011 1:45 am | by The Associated Press | Comments

Digirad Corporation (NASDAQ: DRAD) today announced that it has received Conformite Europeene (CE) Mark approval enabling the Company to market and distribute its ergo large field-of-view, general-purpose portable imaging system throughout Europe and other countries governed by the CE...

STAAR Surgical's Visian® ICL Surpasses 200,000 Implants

January 4, 2011 1:34 am | by Bio-Medicine.Org | Comments

MONROVIA, Calif., Jan. 4, 2011 /- STAAR Surgical Company (Nasdaq: STAA ), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that the worldwide total number of Visian® ICL implants in patients has exceeded 200,000.  Since...

TOPICS:

MEMSIC, INC. (NASDAQ: MEMS) closes above 200-day moving average, hits $3.40

January 3, 2011 11:36 pm | by I-Micronews | Comments

Shares of MEMSIC, INC. (NASDAQ: MEMS) closed above its 200-day moving average on Friday. The stock has a 200-day moving average of $2.70 and last traded at $3.40.

QMT plans to invest nearly US$1 billion on a new manufacturing plant in Taiwan

January 3, 2011 11:36 pm | by I-Micronews | Comments

Taiwan?s flat panel display sector is set to receive a new member with the proposed investment plan by the U.S.-based Qualcomm Mems Technologies Inc. in northern Taiwan.

SPTS ships APS Etch System To Fraunhofer ISIT

January 3, 2011 8:36 pm | by I-Micronews | Comments

SPP Process Technology Systems (SPTS), a supplier of advanced capital equipment and process technologies for the global semiconductor industry and related markets, today announced that it has shipped an APS etch system to Fraunhofer ISIT (FhG-ISIT).

Advertisement

Lextar demonstrates production of 6-inch LED epitaxial wafers

January 3, 2011 8:36 pm | by I-Micronews | Comments

Lextar Electronics of Taiwan, a subsidiary of AU Optronics has produced its first 6-inch LED epitaxial wafer, according to the company and a Digitimes article.

Credit card-sized diagnostic platform provides fast sepsis test

January 3, 2011 8:36 pm | by I-Micronews | Comments

A fast and easy test for sepsis, or blood poisoning as it is commonly known, has been developed by researchers at the Fraunhofer Institute for Cell Therapy and Immunology, Germany.

Medicare payments for medical imaging are higher to nonradiologist physicians than to radiologists

January 3, 2011 8:33 pm | by EurekAlert | Comments

(American College of Radiology / American Roentgen Ray Society) Researchers have found that Medicare payments for non-invasive medical imaging, including magnetic resonance imaging and computed tomography scans, are now higher to non-radiologists than to radiologists, according to a study...

TOPICS:

Albuterol Sulfate Inhalation Solution 0.083%, 3 mL Unit Dose Vials: Recall - Mislabeled Unit Dose Vials

January 3, 2011 10:35 am | by U.S. Food & Drug Administration | Comments

Potenial for dosing error leading to albuterol toxicity.

Rock Hard Extreme and Passion Coffee by Drive Total Energy: Recall - Undeclared Drug Ingredient

January 3, 2011 9:30 am | by U.S. Food & Drug Administration | Comments

Products marketed as dietary supplements contain undeclared analogue of sildenafil, a drug which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.

TOPICS:

Stryker buys Boston Scientific neurovascular unit

January 3, 2011 8:45 am | by The Associated Press | Comments

Stryker Corp. said Monday it closed its $1.5 billion acquisition of Boston Scientific Corp.' neurovascular business.The neurovascular business is based in Fremont, Calif., and makes devices that are used to treat brain aneurysms and other vascular diseases that affect the brain. Its products...

Sector Snap: Medical device makers in 2011

January 3, 2011 7:45 am | by The Associated Press | Comments

A William Blair & Co. analyst said Monday that 2011 will be a difficult year for medical device makers, but he predicted it will be a better year than 2010.Analyst Matthew O'Brien said revenue growth will increase because spinal procedure volumes will bounce back and demand for procedures on...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading